Identifier |
Protein names |
Gene names |
Cross reference refseq |
Length |
Species |
P23294
|
Myelin proteolipid protein; PLP; Lipophilin;
|
PLP1; PLP;
|
NP_001013856.1;
|
277
|
dog
|
P23685
|
Sodium/calcium exchanger 1; Na(+)/Ca(2+)-exchange protein 1; Solute carrier family 8 member 1;
|
SLC8A1;
|
NULL
|
970
|
dog
|
Q0X0E5
|
NADH-cytochrome b5 reductase 3; B5R; Cytochrome b5 reductase; EC 1.6.2.2; Diaphorase-1; [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form];
|
CYB5R3; C5BR DIA1;
|
NP_001041549.1;
|
301
|
dog
|
Q50KA9
|
Nucleoside diphosphate kinase A; NDK A; NDP kinase A; EC 2.7.4.6; nm23-C1;
|
NME1; NM23A;
|
NP_001019808.1;XP_005624397.1;XP_005624398.1;
|
152
|
dog
|
Q50KA8
|
Nucleoside diphosphate kinase B; NDK B; NDP kinase B; EC 2.7.4.6; Histidine protein kinase NDKB; EC 2.7.13.3; nm23-C2;
|
NME2; NM23B;
|
NP_001019809.1;XP_005624399.1;
|
152
|
dog
|
P54713
|
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10; Complex I-42kD; CI-42kD; NADH-ubiquinone oxidoreductase 42 kDa subunit; Fragment;
|
NDUFA10;
|
NULL
|
12
|
dog
|
P49820
|
NADH dehydrogenase [ubiquinone] flavoprotein 2; EC 1.6.5.3; EC 1.6.99.3; NADH-ubiquinone oxidoreductase 24 kDa subunit; Fragment;
|
NDUFV2;
|
NULL
|
11
|
dog
|
P10673
|
Neurotensin/neuromedin N; [Cleaved into: Large neuromedin N (NmN-125); Neuromedin N (NN) (NmN); Neurotensin (NT); NT-tail; Tail peptide];
|
NTS;
|
XP_854478.1;
|
170
|
dog
|
Q6F3J0
|
Nuclear factor NF-kappa-B p105 subunit; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; [Cleaved into: Nuclear factor NF-kappa-B p50 subunit];
|
NFKB1;
|
NP_001003344.1;
|
972
|
dog
|
Q6WZ18
|
Neuroglobin;
|
NGB;
|
NP_001003356.2;
|
151
|
dog
|
Q861Y6
|
Nicolin-1; Tubulin polyglutamylase complex subunit 5; PGs5;
|
NICN1;
|
NP_001029167.1;
|
213
|
dog
|
Q5DUB3
|
Substance-P receptor; SPR; NK-1 receptor; NK-1R; Tachykinin receptor 1;
|
TACR1;
|
NP_001012637.1;
|
407
|
dog
|
Q5DUB2
|
Substance-K receptor; SKR; NK-2 receptor; NK-2R; Neurokinin A receptor; Tachykinin receptor 2;
|
TACR2;
|
NP_001012635.1;
|
384
|
dog
|
E2QWQ2
|
Serine/threonine-protein kinase NLK; EC 2.7.11.24; Nemo-like kinase;
|
NLK;
|
XP_868108.2;
|
527
|
dog
|
Q5R1P3
|
Glutamate receptor ionotropic, NMDA 2B; GluN2B; Glutamate [NMDA] receptor subunit epsilon-2; N-methyl D-aspartate receptor subtype 2B; NMDAR2B; NR2B;
|
GRIN2B;
|
NP_001008719.1;XP_005636773.1;
|
1485
|
dog
|
Q5R1P0
|
Glutamate receptor ionotropic, NMDA 1; GluN1; Glutamate [NMDA] receptor subunit zeta-1; N-methyl-D-aspartate receptor 1; N-methyl-D-aspartate receptor subunit NR1; NMD-R1;
|
GRIN1; NMDAR1;
|
NP_001008717.1;
|
943
|
dog
|
P34962
|
Neuromedin-U-25; NmU-25; [Cleaved into: Neuromedin-U-8 (NmU-8)];
|
NMU;
|
NULL
|
25
|
dog
|
E2QUI9
|
ATP-dependent (S)-NAD(P)H-hydrate dehydratase; EC 4.2.1.93; ATP-dependent NAD(P)HX dehydratase; Carbohydrate kinase domain-containing protein;
|
CARKD;
|
NULL
|
347
|
dog
|
E2QRY6
|
NAD(P)H-hydrate epimerase; EC 5.1.99.6; Apolipoprotein A-I-binding protein; AI-BP; NAD(P)HX epimerase;
|
APOA1BP; AIBP;
|
NULL
|
288
|
dog
|
O62699
|
Nitric oxide synthase, inducible; EC 1.14.13.39; Inducible NO synthase; Inducible NOS; iNOS; NOS type II; Peptidyl-cysteine S-nitrosylase NOS2;
|
NOS2;
|
NP_001003186.1;
|
1154
|
dog
|